Cerebral stroke is a leading cause of death and permanent disability. The current therapeutic outcome of ischemic stroke (>85% of all strokes) is very poor, thus novel therapeutic drug is urgently needed. In vitro cell model of ischemia was established by oxygen-glucose deprivation (OGD) and in vivo animal model of ischemia was established by middle cerebral artery occlusion (MCAO). The effects of Spatholobus suberctus Dunn extract (SSCE) on OGD-induced cell injury, MCAO-induced neural injury and miR-494 level were all evaluated. The possible target genes were virtually screened utilizing bioinformatics and verified by luciferase assay. Subsequently, the effects of abnormally expressed miR-494 on OGDinduced cell injury and target gene expression were determined. Additionally, whether SSCE affected target gene expression through modulation of miR-494 was studied. Finally, the effects of aberrantly expressed Sox8 on OGD-induced injury and signaling pathways were estimated. SSCE reduced OGD-induced cell injury and ameliorated MCAO-induced neuronal injury, along with down-regulation of miR-494. Then, OGD-induced cell injury was increased by miR-494 overexpression but decreased by miR-494 silence. Sox8 was a target gene of miR-494, and SSCE could up-regulate Sox8 expression via down-regulating miR-494. Afterwards, OGD-induced cell injury was proved to be increased by Sox8 inhibition but reduced by Sox8 overexpression. Finally, OGD-induced inhibition of PI3K/AKT/mTOR and MAPK pathways was further inhibited by Sox8 silence but activated by Sox8 overexpression. SSCE ameliorates ischemia-induced injury both in vitro and in vivo by miR-494-mediated modulation of Sox8, involving activations of PI3K/AKT/mTOR and MAPK pathways.
Introduction
Cerebral stroke, also termed stroke or cerebral vascular accident, is an acute cerebral vascular disease which includes multiple forms, such as ischemic stroke, subarachnoid hemorrhage and intracerebral hemorrhage [1] . It has been estimated to be the second most common cause of a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 overnight. Then, the supernatant was centrifuged, evaporated, and dried in a vacuum oven (0.01 Pa) at 60˚C for 6 h. Dissolved in Mili-Q water, the crude extract was subjected to polyamide column chromatography, and eluted with 0%, 30% and 95% ethanol in turns. Fractions eluted with 30% ethanol were collected, evaporated and dried in a vacuum oven to obtain 13.89 g SSCE. Subsequently, SSCE was dissolved in dimethyl sulfoxide (DMSO) and the concentration was 1 g/mL. For the following experiments, SSCE was diluted with culture media to a final concentration of 5 μg/mL.
Cell Counting Kit-8 (CCK-8) assay
Cell viability was measured by using a CCK-8 (Dojindo, Gaithersburg, MD, USA) in accordance with the supplier's instructions. Briefly, cells were seeded into 96-well plates with a density of 5 × 10 3 cells/well and cultured. After treatments, 10 μL of CCK-8 solution was added to each well and the mixture was incubated at 37˚C for 1 h under normal condition. The absorbance at 450 nm was determined using a microplate reader (Bio-Rad, Hercules, CA, USA).
Apoptosis assay
Cell apoptosis was estimated by Flow cytometry analysis following the protocol of Annexin V-FITC/propidium iodide (PI) apoptosis detection kit (Beijing Biosea Biotechnology, Beijing, China). Briefly, 1 × 10 5 cells were seeded in each well of 6-well plates and cultured. After treatments, cells were collected, washed with cold phosphate-buffered saline (PBS) and resuspended in binding buffer. The cells were then stained with 10 μL Annexin V-FITC and 5 μL PI in the dark, followed by measurements with a flow cytometer (Beckman Coulter, Miami, FL, USA).
miR transfection
miR-494 mimic, miR-494 inhibitor and their controls (mimic control and inhibitor control) were synthesized by GenePharma Co. (Shanghai, China). These miRs were transfected into PC12 cells using Lipofectamine 3000 reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's instructions.
Transfection and generation of stably transfected cell lines
The full-length rat Sox8 sequences were sub-cloned into pEX-2 plasmid (GenePharma) to generate pEX-Sox8. Short-hairpin RNA directed against rat Sox8 were constructed into U6/GFP/ Neo plasmid (GenePharma) to generate sh-Sox8. The empty pEX-2 plasmid and U6/GFP/Neo plasmid carrying a non-targeting sequence (sh-NC) were used as negative controls of pEXSox8 and sh-Sox8, respectively. These recombined plasmids were respectively transfected into PC12 cells by using Lipofectamine 3000 reagent (Invitrogen) following the manufacturer's instructions. Culture medium supplemented with 0.5 mg/mL G418 (Sigma-Aldrich, St Louis, MO, USA) was used for selection of stably transfected cells. Approximately 4 weeks later, the PC12 cell lines with stable transfection (G418-resistant cells) were established.
Quantitative reverse transcription PCR (qRT-PCR)
Trizol reagent and Ambion 1 DNase I (both from Invitrogen) were used for extraction of total RNA according to the manufacturer's protocol. On the basis of protocols of suppliers, Taqman MicroRNA Reverse Transcription Kit (for quantification of miR-494) and Multiscribe RT kit (for quantification of Sox8) (both from Applied Biosystems, Foster City, CA, USA) were used for reverse transcription. Then, quantitation of miR-494 and Sox8 was performed using Taqman Universal Master Mix II (Applied Biosystems) following the protocols of suppliers.
Relative expression was calculated according to the 2 -ΔΔCt method [19] , by normalizing to U6
(miR-494) and GAPDH (Sox8) expression levels, respectively. The Primers were shown in S1 Table. Dual luciferase activity assay
Fragments of wild-type rat Sox8 3'UTR containing the putative miR-494-binding sites were sub-cloned into the pmirGLO vector (Promega, Madison, WI, USA), and the resultant plasmid was referred to as Sox8-WT. The recombined Sox8-WT was served as a template for sitemutation using Directed Mutagenesis System (Invitrogen) to generate Sox8-Mut. Then, cells were co-transfected with Sox8-WT (Sox8-Mut) and miR-494 mimic (mimic control) using Lipofectamine 3000 reagent (Invitrogen), followed by estimation of luciferase activity using the dual-luciferase assay system (Promega) in accordance with the manufacturer's information.
Western blot analysis
The protein of cells was extracted using RIPA lysis buffer (Beyotime Biotechnology, Shanghai, China) supplemented with phosphatase inhibitor cocktail (Sigma-Aldrich) and protease inhibitor cocktail (Roche, Indianapolis, IN, USA). After quantification with the BCA™ Protein Assay Kit (Pierce, Appleton, WI, USA), equivalent proteins were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Then, proteins in the gels were transferred to polyvinylidene difluoride (PVDF) membranes (Millipore), and the membranes were blocked by 5% skim milk. After washing, membranes were incubated at 4˚C overnight with primary antibodies against B cell lymphoma-2 (Bcl-2, ab196495), Bcl-2-associated X protein (Bax, ab182733), pro caspase-3 (ab90437), cleaved caspase-3 (ab49822), phosphatidylinositol-3-kinase (PI3K, ab191606), phosphorylated PI3K (p-PI3K, ab182651), GAPDH (ab181603) (all from Abcam, Cambridge, UK), pro caspase-9 (9508), cleaved caspase-9 (9507), AKT (9272), phosphorylated AKT (p-AKT, 9271), mechanistic target of rapamycin (mTOR, 2972), phosphorylated mTOR (p-mTOR, 2971), mitogen-activated protein kinase (MAPK, 9212), phosphorylated MAPK (p-MAPK, 9211) (all from Cell Signaling Technology, Beverly, MA, USA) or Sox8 (sc-374445, Santa Cruz, Santa Cruz, CA, USA). After washing again, the membranes were incubated with secondary antibodies marked by horseradish peroxidase for 1 h at room temperature. The PVDF membranes were washed and reacted with an enhanced chemiluminescence (ECL) system (Amersham Biosciences, Piscataway, New Jersey, USA). The signals were captured and detected using Image Lab™ software (Bio-Rad), and the intensity of bands was analyzed using Image J software (version 1.46; National Institutes of Health, Bethesda, MD, USA).
Surgical procedure and grouping of rats
Middle cerebral artery occlusion (MCAO) was carried out for construction of stroke model in rats as described previously [20] . In brief, after anesthetization, the right common (CCA), right external (ECA) and right internal (ICA) carotid arteries were exposed and a nylon suture was inserted into CCA and advanced up to the origin of the MCA. 
Modified neurological severity scores (mNSSs)
Neurological deficits were assessed using mNSSs at 2, 5, 8, 11, or 14 days post-MCAO as described previously [21] . In brief, a blinded assessor scored the neurological deficits of rats on the basis of an 18-point scale. The score of 0 was referred to as normal and the score of 18 was referred to as maximal deficit.
Rota-rod test
Motor coordination and learning ability was evaluated by rota-rod test as described previously [21] . A day before surgery, rats received a training on a rota-rod apparatus (diameter 6.0 cm, Ugo Basile, Milano, Italy) with a constant speed at 3 rpm until they could remain on the rotating spindle for 180 s. The measurements with a spindle speeds of 5 rpm and 15 rpm were performed at 2, 5, 8, 11, and 14 days post-MCAO, and the residence times on the spindle were recorded. Rats were rested for 1 h between two trials.
Infarct volume assessment
After 14 days of maintaining, rats were sacrificed and the whole brains were separated and cut into 2-mm slices coronally. Subsequently, the brain slices were incubated in 2% 2, 3, 5-triphenyltetrazolium chloride (TTC; Sigma-Aldrich) at 37˚C for 30 min in the dark, and then fixed with 4% paraformaldehyde. The infarct volume was analyzed by Image J software and was calculated by multiplying infarct areas by thickness. Besides, the infarct areas were normalized through multiplying measured areas by ipsilateral to contralateral hemisphere area ratios.
Statistical analysis
All experiments were repeated three times. The results of multiple experiments were presented as the mean ± standard error of the mean (SEM). Statistical analysis was performed using Graphpad Prism 5 software (GraphPad, San Diego, CA, USA). The P-values were calculated using the one-way analysis of variance (ANOVA) with post hoc Bonferroni's correction. A Pvalue of <0.05 was considered to indicate a statistically significant result.
Results

OGD induced cell injury in PC12 cells
Cell viability and apoptosis were assessed at 0, 2, 4, 6 and 8 h post-OGD. When the OGD lasted for 4 h or longer, cell viability was markedly decreased compared with non-treated cells (P < 0.05, P < 0.01 or P < 0.001, Fig 1A) . Conversely, percentages of apoptotic cells were significantly elevated by 2 h, 4 h (both P < 0.05), 6 h and 8 h (both P < 0.001) of OGD treatments ( Fig 1B and S1 Fig) . Meantime, the pro-apoptotic Bax, active caspase-3 and active caspase-9 were all up-regulated gradually as the increasing of OGD duration, whereas anti-apoptotic Bcl-2 showed the opposite trend (Fig 1C and 1D) . Results illustrated that OGD could induce cell injury in PC12 cells, and the duration of OGD was 6 h for the subsequent experiments.
Preconditioning with SSCE protected PC12 cells against OGD-induced injury
Cell viability was markedly reduced with the presence of 10-20 μg/μl SSCE (P < 0.05 or P < 0.001) whereas the reduction under 5 μg/μl SSCE was non-significant, indicating the maximal dose of SSCE was 5 μg/μl (Fig 2A) . Results in Fig 2B showed the decreased cell viability induced by OGD was remarkably increased by 2-5 μg/μl SSCE preconditioning compared with OGD group (P < 0.05). Oppositely, the increased cell apoptosis induced by OGD was significantly reduced by 2-5 μg/μl SSCE preconditioning compared with OGD group (P < 0.05 or P < 0.01, Fig 2C and S2 Fig) . Meantime, the OGD-induced alterations of apoptosis-associated proteins at protein level were all significantly decreased by 2-5 μg/μl SSCE preconditioning (Fig 2D and 2E) . The effects of 1 μg/μl SSCE on OGD-induced injury were non-significant. The results indicated that preconditioning with SSCE protected PC12 cells against OGDinduced injury in a dose-dependent manner.
SSCE reduced infarct volume and improved neurological deficits and motor impairments
Next, the in vivo effects of SSCE on rats with MCAO were further evaluated. After 14 days of maintaining, there was nearly no infarct volume in the brain slices of sham group whereas that Protein expression of apoptosis-associated proteins by Western blot analysis. Data are presented as the mean ± standard error of the mean (SEM). *, P < 0.05; **, P < 0.01; ***, P < 0.001. Bcl-2, B cell lymphoma-2; Bax, Bcl-2-associated X protein; P-, pro; C-, cleaved; C/P-, cleaved/pro.
Fig 2. Oxygen and glucose deprivation (OGD)-induced cell injury is attenuated by Spatholobus suberctus Dunn extract (SSCE). A-B.
Cell viability by Cell Counting Kit-8 assay. C. Cell apoptosis by flow cytometry. D-E. Protein expression of apoptosis-associated proteins by Western blot analysis. Data are presented as the mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Bcl-2, B cell lymphoma-2; Bax, Bcl-2-associated X protein; P-, pro; C-, cleaved; C/P-, cleaved/pro.
of the MCAO group was approximately 140 mm 3 (Fig 3A) . Compared with the MCAO group, infarct volume was significantly reduced by 20 mg/kg SSCE (P < 0.05), 40 mg/kg SSCE (P < 0.01) and 80 mg/kg SSCE (P < 0.01). Likewise, the mNSSs of rats in the Sham group were nearly zero whereas that in the MCAO group was about 7-10 at 2-14 days post-MCAO ( Fig  3B) . The mNSSs was markedly reduced by the treatments of SSCE at 2-14 days post-MCAO (P < 0.05 or P < 0.01). In addition, the residence times on the spindle at both 5 and 15 rpm were significantly reduced by MCAO compared with the Sham group (P < 0.001, Fig 3C and  3D) . Administration of SSCE markedly prolonged the residence times at 2-14 days post-MCAO compared with the MCAO group (P < 0.05, P < 0.01 or P < 0.001). Results indicated that SSCE reduced infarct volume and improved neurological deficits and motor impairments. SSCE down-regulated miR-494 in PC12 cells
Subsequently, we explored the change of miR-494 in PC12 cells during OGD. Expression of miR-494 was significantly up-regulated at 4 h (P < 0.05), 6 h and 8 h (both P < 0.01) post-OGD (Fig 4A) . Data in Fig 4B showed the OGD induced up-regulation of miR-494 was reversed by SSCE preconditioning compared with the OGD group (P < 0.01), indicating SSCE could down-regulate miR-494 in PC12 cells during OGD. 
OGD-induced injury was increased by miR-494 overexpression but was reversed by miR-494 inhibition
To explore the influence of miR-494, miR-494 was aberrantly expressed in PC12 cells via cell transfection. In Fig 5A, miR-494 was significantly up-regulated in cells transfected with miR-494 mimic compared with the mimic control group while was dramatically down-regulated in cells transfected with miR-494 inhibitor compared with the inhibitor control group (both P < 0.01), suggesting miR-494 was abnormally expressed after transfection. CCK-8 assay showed OGD-induced decreases of cell viability were further decreased by miR-494 overexpression but were elevated by miR-494 inhibition when compared to respective controls (both P < 0.05, Fig 5B) . Conversely, OGD-induced elevation of cell apoptosis was further increased by miR-494 overexpression while was decreased by miR-494 silence when compared to respective controls (both P < 0.05, Fig 5C and S3 Fig) . Moreover, the alterations of apoptosis-associated proteins induced by OGD were significantly increased by miR-494 overexpression (P < 0.05 or P < 0.01) but were reduced by miR-494 inhibition (P < 0.01 or P < 0.001, Fig 5D  and 5E ). Taken together, we concluded that abnormal expression of miR-494 affected OGDinduced cell injury in PC12 cells.
miR-494 negatively correlated with Sox8 expression
Predicted by bioinformatics, Sox8 was supposed to be a target of miR-494. First of all, the expression of Sox8 in OGD-treated PC12 cells was estimated. Results in Fig 6A showed Sox8 mRNA expression was significantly down-regulated at 4 h (P < 0.05), 6 h (P < 0.01) and 8 h (P < 0.001) post-OGD, which was opposite to the alteration of miR-494. In Fig 6B-6D , mRNA and protein levels of Sox8 were observably reduced by miR-494 overexpression but were significantly increased by miR-494 inhibition when compared with respective controls (P < 0.05 or P < 0.01), suggesting that miR-494 could negatively regulate Sox8 expression. The following luciferase assay verified the direct interaction between miR-494 and Sox8 3'UTR, presenting that luciferase activity was markedly reduced by co-transfection with Sox8-WT and miR-494 mimic compared with co-transfection with Sox8-WT and mimic control (P < 0.05) whereas the difference between co-transfections with Sox8-Mut was non-significant (Fig 6E) . Therefore, we were suggestive of negative regulations between miR-494 and Sox8.
SSCE up-regulated Sox8 through down-regulating miR-494
To identify whether SSCE affected expression of Sox8 through modulating miR-494, cells transfected with mimic control or miR-494 were treated with OGD and SSCE. In Fig 7A-7C , OGD obviously decreased expression of Sox8 compared with the control group (P < 0.01), whereas the down-regulation of Sox8 was remarkably increased by SSCE preconditioning compared with the OGD group (P < 0.01 or P < 0.001). Moreover, the SSCE induced up-regulation of Sox8 was dramatically decreased by miR-494 overexpression compared with the mimic control+OGD+SSCE group (P < 0.01 or P < 0.001). All the results implied SSCE upregulated Sox8 through down-regulating miR-494.
OGD-induced injury was reduced by Sox8 overexpression but was increased by Sox8 silence
To figure out the influence of Sox8 on PC12 cells with OGD, stably transfected cell lines were constructed. As evidence from Fig 8A-8C , both mRNA and protein expression of Sox8 were obviously elevated in pEX-Sox8 transfected cells (P < 0.01 or P < 0.001) but were significantly reduced in sh-Sox8 transfected cells compared with respective controls (P < 0.01). When compared to pEX-2 group, OGD-induced decrease of cell viability as well as OGD-induced increase of cell apoptosis were both attenuated markedly (P < 0.05 or P < 0.01) by Sox8 Data are presented as the mean ± SEM. *, P < 0.05; **, P < 0.01. Bcl-2, B cell lymphoma-2; Bax, Bcl-2-associated X protein; P-pro; C-, cleaved.
https://doi.org/10.1371/journal.pone.0184348.g005
Role of SSCE in ischemia-induced injury overexpression, whereas the effects of Sox8 inhibition on cell viability and apoptosis were just the opposite (Fig 8D and 8E and S4 Fig) . Additionally, the changes of apoptosis-associated proteins induced by OGD were further increased by Sox8 inhibition while were reversed by Sox8 overexpression (Fig 8F and 8G) . As a consequence, we concluded that OGD-induced injury could be decreased by Sox8 overexpression but was increased by Sox8 silence.
Sox8 overexpression decreased OGD-induced injury by activation of PI3K/AKT/mTOR and MAPK pathways
To reveal the underlying mechanisms of Sox8-associated regulations, the phosphorylation of key kinases involved in PI3K/AKT/mTOR and MAPK pathways was evaluated. Western blotting results showed phosphorylation levels of PI3K, AKT, mTOR and MAPK were all significantly reduced by OGD treatment (P < 0.01, Fig 9A-9D) . Meanwhile, the OGD-induced reduction of these phosphorylated kinases was reversed by Sox8 overexpression (P < 0.001) but was further reduced by Sox8 inhibition (P < 0.01), indicating that abnormal expression of Relative luciferase activity by luciferase assay. Data are presented as the mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Sox8-WT, pmirGLO vector containing fragments of wildtype rat Sox8 3'UTR; Sox8-Mut, mutant Sox8-WT.
https://doi.org/10.1371/journal.pone.0184348.g006
Role of SSCE in ischemia-induced injury Sox8 affected OGD-induced injury by modulation of PI3K/AKT/mTOR and MAPK pathways.
Discussion
Stroke is not only a major cause of mortality but also a leading reason of permanent disability worldwide [22] . The outcome of ischemic stroke, majority of all strokes, remains very poor although mounting studies have identified various neuroprotective agents. Thus, more studies should be focused on the exploration of effective therapeutic drugs for ischemic stroke. In our study, we established cell model and animal model of ischemic stroke and interestingly identified SSCE could decrease OGD-induced cell injury, reduced infarct volume and improved neurological deficits and motor impairments. Then, miR-494 was found to be up-regulated after OGD treatment but down-regulated by SSCE preconditioning. Following experiments proved that abnormally expressed miR-494 affected OGD-induced cell injury by targeting Sox8 expression. Not surprisingly, the aberrantly expressed Sox8 was also proved to modulate OGD-induced cell injury. Moreover, PI3K/AKT/mTOR and MAPK pathways were involved in OGD treatment and the protective effect of Sox8 on OGD-induced cells.
The neuroprotective effects of SSCE on ischemic stroke were verified both in vitro and in vivo. Overwhelming evidence suggests cell death was observed and considered as the predominant phenomenon of ischemia-induced damage [23, 24] . In our study, OGD-induced decrease of cell viability and increase of cell apoptosis were all decreased by 2-5 μg/μl SSCE, suggesting the neuroprotective roles of SSCE in vitro. In vivo model of ischemic stroke was constructed through MCAO, by which the infarct volume was produced and the neurological deficits and motor impairments were observed. Administration of SSCE in rats effectively reduced infarct volume and improves neurological deficits and motor impairments, suggesting the neuroprotective roles of SSCE in vivo.
A literature demonstrated miR-494 suppression decrease carotid artery atherosclerotic lesion, suggesting a potential reduction of the ischemic stroke risk [25] . Results in our study stated miR-494 was up-regulated after OGD and the up-regulation could be reversed by SSCE treatment, indicating that miR-494 was associated with the protective effect of SSCE on OGDinduced injury. Subsequently, the specific effects of aberrantly expressed miR-494 on OGDinduced PC12 cells were verified. Results stated that OGD-induced reduction of cell viability was further decreased whereas OGD-induced enhancement of cell apoptosis was further increased by miR-494 overexpression. The inhibition on cell viability and the promotion on cell apoptosis of miR-494 in our study were consistent with previous studies [26, 27] .
In common, miRs function through binding to 3'UTR of target genes, thus we screened the possible target genes of miR-494 by TargetScan virtually. Sex determining region Y-related high mobility group box (Sox) family proteins are involved in multiple pathological and physiological processes, including tumor progression [28, 29] . Sox8 has been reported as the target gene of miR-124 and suppresses cell proliferation in non-small lung cell carcinoma [30] . Another study also proved that Sox8 is a oncogenic gene in hepatocellular carcinoma [31] . Thus, we hypothesized Sox8 might affect cell proliferation and apoptosis of PC12 cells and thereby affect OGD-induced cell injury. As a consequence, we focused on the Sox8 among those screened target genes of miR-494. Results in our study illustrated that Sox8 was Data are presented as the mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Bcl-2, B cell lymphoma-2; Bax, Bcl-2-associated X protein; P-, pro; C-, cleaved; pEX-Sox8, pEX-2 plasmid carrying full-length rat Sox8 sequences; sh-Sox8, U6/GFP/Neo plasmid carrying short-hairpin RNA directed against rat Sox8; sh-NC, U6/GFP/Neo plasmid carrying a non-targeting sequence.
negatively regulated by miR-494, making us confirm Sox8 was a target gene of miR-494. The subsequent luciferase activity assay also consolidated the conclusion.
Afterwards, miR-494 was aberrantly expressed in PC12 cell, and the transfected cells were treated with OGD+SSCE in order to verify whether SSCE regulated Sox8 expression through regulating miR-494. Results in our study illustrated that SSCE could reverse OGD-induced down-regulation of Sox8, and the effect of SSCE could be abrogated be miR-494 overexpression, meaning that SSCE could regulate Sox8 expression through modulating miR-494. In addition, we performed additional experiments to fully verify the effect of abnormally expressed Sox8 on PC12 cell with OGD treatment. In detail, the decrease of cell viability induced by OGD was further reduced by Sox8 silence but reversed by Sox8 overexpression, and the increase of cell apoptosis induced by OGD was further enhanced by Sox8 silence but reversed by Sox8 overexpression. Therefore, Sox8 was identified to reduce OGD-induced cell injury by affecting cell viability and apoptosis, which was consistent with previous studies [30, 32] .
Accumulating evidence has proved that PI3K/AKT/mTOR and MAPK signaling pathways are closely related to cell proliferation and apoptosis [33, 34] . PC12 cell apoptosis, induced by sodium nitroprusside or β-amyloid, has been reported to be repressed through PI3K/AKT/ mTOR pathway [35, 36] . Likewise, cell apoptosis of PC12 cells could be suppressed by nobiletin [37] or gastrodin [38] through MAPK signaling pathway. Hence, to reveal underlying mechanism A-B) and MAPK (C-D) pathways were determined by Western blot analysis. Data are presented as the mean ± SEM. **, P < 0.01; ***, P < 0.001. pEX-Sox8, pEX-2 plasmid carrying full-length rat Sox8 sequences; sh-Sox8, U6/ GFP/Neo plasmid carrying short-hairpin RNA directed against rat Sox8; sh-NC, U6/GFP/Neo plasmid carrying a non-targeting sequence; PI3K, phosphatidylinositol-3-kinase; mTOR, mechanistic target of rapamycin; MAPK, mitogen-activated protein kinase; p-, phosphorylated.
https://doi.org/10.1371/journal.pone.0184348.g009
Role of SSCE in ischemia-induced injury of SSCE modulation, the phosphorylation levels of key kinases involved in PI3K/AKT/mTOR and MAPK pathways were determined in PC12 cells with aberrantly expressed Sox8. Results in our study proposed that these two pathways were inhibited by OGD and further inhibited by Sox8 silence, while was activated by Sox8 overexpression. Therefore, activations of these two signaling pathways were involved in Sox8-mediated protection against OGD-induced injury in PC12 cells.
Collectively, SSCE was interestingly identified to improve ischemia-induced neuronal injury both in vitro and in vivo, and the protective effects were associated with miR-494. Further studies proved that the SSCE functioned through down-regulation of miR-494 by targeting Sox8, involving in activation of PI3K/AKT/mTOR and MAPK pathways. This study illustrated the potential role of SSCE in ischemic stroke and explained the underlying molecular mechanism, providing the theoretical basis for the traditional therapy with Chinese herbs. 
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